Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: Reduction of erythropoietin dose in 4 years of follow-up

Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: Reduction of erythropoietin dose in 4 years of follow-up

Background : : Ferric carboxymaltose (FCM) is a parenteral, dextran-free iron formulation designed to overcome the limitations of existing iron preparations. The main aim of this study was to retrospectively examine results obtained from a long period of FCM therapy in hemodialysis patients who have...

Full description

Saved in:
Bibliographic Details
Main Authors: Antonio Lacquaniti (Author), Patrizio Pasqualetti (Author), Teresa Casuscelli di Tocco (Author), Susanna Campo (Author), Stefania Rovito (Author), Maurizio Bucca (Author), Antonino Ragusa (Author), Paolo Monardo (Author)
Format: Book
Published: The Korean Society of Nephrology, 2020-09-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items